The use of intravenous immunoglobulin for neurologic diseases
By: Marinos C. Dalakas, supplement editor.
Contributors: Dalakas, Marinos C.
Series: Neurology -- v. 51, no. 6, Supplement 5 (December 1998); Neurology -- v. 51, no. 6.
Publisher: Lippincott Williams & Wilkins
Published: 1998
Place of publication: Hagerstown, MD
Language: eng
Number of pages: 45
Subjects: Immunoglobulins -- Therapeutic use.; Neuromuscular diseases -- Chemotherapy.
Notes: "Prepared for publication by CoMed Communications, Inc., Philadelphia ... from the Expert Panel Consensus on The use of intravenous immunoglobulin for neurologic diseases, on April 4, 1998 in McLean, Virginia"--T.p. verso.

Includes bibliographical references.
Table of contents: value: The use of intravenous immunoglobulin for neurologic diseases / M.C. Dalakas; value: Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases / M.C. Dalakas; value: Treatment of Guillain-Barré Syndrome with intravenous immunoglobulin / R.A. Sater and A.M. Rostami; value: Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin / A.F. Hahn; value: Multifocal motor neuropathy : diagnosis and treatment / A. Pestronk; value: Intravenous immunoglobulins in multiple sclerosis / R.P. Lisak; value: Intravenous immunoglobulin for the treatment of acquired myasthenia gravis / J.F. Howard, Jr.; value: Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis / M.C. Dalakas.